Alveus Therapeutics
Developer of biologic and small molecule treatments designed for metabolic disease management. The company's platform combines genetic analysis, biological insights, and empirical data to develop dual...
Valuation
$123M
Market implied
Share Price
N/A
Total Raised
$42.9M
Last Round
N/A